Unraveling the global burden of inflammatory bowel disease (1990–2019): A Joinpoint regression analysis of divergent trends in 10–24 and 50–69 age cohorts

IF 9.2 1区 医学 Q1 IMMUNOLOGY
Xinyi Wang , Ruipu Xiu , Liping Gong , Wei Sun , Yuxin Dong , Weitong Liu , Xiaoxuan Liu , Chuanyong Liu , Jingxin Li , Yanqing Wang
{"title":"Unraveling the global burden of inflammatory bowel disease (1990–2019): A Joinpoint regression analysis of divergent trends in 10–24 and 50–69 age cohorts","authors":"Xinyi Wang ,&nbsp;Ruipu Xiu ,&nbsp;Liping Gong ,&nbsp;Wei Sun ,&nbsp;Yuxin Dong ,&nbsp;Weitong Liu ,&nbsp;Xiaoxuan Liu ,&nbsp;Chuanyong Liu ,&nbsp;Jingxin Li ,&nbsp;Yanqing Wang","doi":"10.1016/j.autrev.2024.103586","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and aims</h3><p>The escalating prevalence of IBD within specific age cohorts, 10–24 and 50–69 years, necessitates a refined understanding of its epidemiological patterns. Prior investigations have often been constrained by their limited scope, particularly in employing age-specific analyses and utilizing advanced statistical methods such as joinpoint regression. Our research examines these demographic segments to elucidate the epidemiological trajectory of IBD.</p></div><div><h3>Methods</h3><p>This study analyzed GBD 2019 data on IBD, focusing on age groups 10–24 and 50–69. We integrated the socio-demographic index for socio-economic context and employed joinpoint regression to analyze time-segmented disease trends, prioritizing average annual percent change for a comprehensive view.</p></div><div><h3>Results</h3><p>A notable global decline in IBD incidence, particularly in the 50–69 age group, was observed. The 10–24 cohort, however, presented a marginal rise across three decades, with a discernible decline between 2010 and 2019. The study also revealed pivotal gender disparities, with increasing incidence rates in males, especially in the High-income Asia Pacific region. Conversely, females demonstrated decreasing trends across the board. Regional variations accentuated East Asia's escalated IBD incidence and prevalence, whereas high-income North American and Asia-Pacific regions, along with Europe, reflected the highest age-standardized incidence rates.</p></div><div><h3>Conclusion</h3><p>The burden of IBD between 1990 and 2019 presents notable disparities across different regions and age demographics. While older populations are seeing a decrease in IBD incidence, young adults and adolescents in regions like East Asia and high-income Asia Pacific are experiencing a concerning uptick. This uneven distribution, influenced by both age and gender, underscores the multifaceted nature of IBD's global impact.</p></div>","PeriodicalId":8664,"journal":{"name":"Autoimmunity reviews","volume":"23 6","pages":"Article 103586"},"PeriodicalIF":9.2000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Autoimmunity reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1568997224000776","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aims

The escalating prevalence of IBD within specific age cohorts, 10–24 and 50–69 years, necessitates a refined understanding of its epidemiological patterns. Prior investigations have often been constrained by their limited scope, particularly in employing age-specific analyses and utilizing advanced statistical methods such as joinpoint regression. Our research examines these demographic segments to elucidate the epidemiological trajectory of IBD.

Methods

This study analyzed GBD 2019 data on IBD, focusing on age groups 10–24 and 50–69. We integrated the socio-demographic index for socio-economic context and employed joinpoint regression to analyze time-segmented disease trends, prioritizing average annual percent change for a comprehensive view.

Results

A notable global decline in IBD incidence, particularly in the 50–69 age group, was observed. The 10–24 cohort, however, presented a marginal rise across three decades, with a discernible decline between 2010 and 2019. The study also revealed pivotal gender disparities, with increasing incidence rates in males, especially in the High-income Asia Pacific region. Conversely, females demonstrated decreasing trends across the board. Regional variations accentuated East Asia's escalated IBD incidence and prevalence, whereas high-income North American and Asia-Pacific regions, along with Europe, reflected the highest age-standardized incidence rates.

Conclusion

The burden of IBD between 1990 and 2019 presents notable disparities across different regions and age demographics. While older populations are seeing a decrease in IBD incidence, young adults and adolescents in regions like East Asia and high-income Asia Pacific are experiencing a concerning uptick. This uneven distribution, influenced by both age and gender, underscores the multifaceted nature of IBD's global impact.

揭示炎症性肠病的全球负担(1990-2019 年):对 10-24 岁年龄组和 50-69 岁年龄组不同趋势的连接点回归分析。
背景和目的:IBD 在 10-24 岁和 50-69 岁这两个特定年龄段的发病率不断上升,因此有必要对其流行病学模式进行深入了解。之前的调查往往受到范围有限的限制,尤其是在采用特定年龄分析和使用联结点回归等高级统计方法方面。我们的研究对这些人口学细分进行了研究,以阐明 IBD 的流行病学轨迹:本研究分析了 GBD 2019 有关 IBD 的数据,重点关注 10-24 岁和 50-69 岁年龄组。我们整合了社会经济背景下的社会人口指数,并采用连接点回归分析了疾病的时间分段趋势,优先考虑年均百分比变化,以获得全面的视角:结果:观察到全球 IBD 发病率明显下降,尤其是在 50-69 岁年龄组。然而,10-24 岁年龄组的发病率在三十年间略有上升,2010 年至 2019 年期间出现明显下降。研究还揭示了关键的性别差异,男性发病率不断上升,尤其是在高收入的亚太地区。相反,女性的发病率则呈全面下降趋势。地区差异加剧了东亚地区的 IBD 发病率和流行率,而高收入的北美和亚太地区以及欧洲则反映出最高的年龄标准化发病率:结论:1990 年至 2019 年期间,IBD 的负担在不同地区和年龄人口中呈现出明显的差异。虽然老年人群的 IBD 发病率有所下降,但东亚和高收入亚太地区等地区的年轻成人和青少年的发病率却出现了令人担忧的上升。这种受年龄和性别影响的不均衡分布凸显了 IBD 对全球影响的多面性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Autoimmunity reviews
Autoimmunity reviews 医学-免疫学
CiteScore
24.70
自引率
4.40%
发文量
164
审稿时长
21 days
期刊介绍: Autoimmunity Reviews is a publication that features up-to-date, structured reviews on various topics in the field of autoimmunity. These reviews are written by renowned experts and include demonstrative illustrations and tables. Each article will have a clear "take-home" message for readers. The selection of articles is primarily done by the Editors-in-Chief, based on recommendations from the international Editorial Board. The topics covered in the articles span all areas of autoimmunology, aiming to bridge the gap between basic and clinical sciences. In terms of content, the contributions in basic sciences delve into the pathophysiology and mechanisms of autoimmune disorders, as well as genomics and proteomics. On the other hand, clinical contributions focus on diseases related to autoimmunity, novel therapies, and clinical associations. Autoimmunity Reviews is internationally recognized, and its articles are indexed and abstracted in prestigious databases such as PubMed/Medline, Science Citation Index Expanded, Biosciences Information Services, and Chemical Abstracts.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信